drugset / Trial / NCT05335447
Evaluation of Mass Balance and Absolute Bioavailability of GLPG3667
Non-randomizedSequentialOpen-labelBasic science
Summary
This is a study in healthy male volunteers to assess how a new test medicine is taken up and broken down by the body as well as its safety and tolerability.
Timeline
- Start
- 2022-04-19
- Primary completion
- 2022-06-03
- Completion
- 2022-06-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GLPG3667 | Small molecule | — | Oral |
Indications
No indication recorded.